<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01556204</url>
  </required_header>
  <id_info>
    <org_study_id>12-173</org_study_id>
    <nct_id>NCT01556204</nct_id>
  </id_info>
  <brief_title>Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial</brief_title>
  <acronym>LAROSE</acronym>
  <official_title>Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to conduct a prospective randomized controlled trial of
      robotic-assisted versus conventional laparoscopy for the treatment of endometriosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized control trial. Study subjects will be recruited from
      patients that present to the Department of Gynecology who are to have surgery for
      endometriosis at the Cleveland Clinic.

      Patient that require bowel resection and/or ureteral reanastomosis are not included due to
      the fact that these events impact operating time significantly and are not commonly performed
      as part of endometriosis surgery (subjects may not be equally distributed among both arms).

      Eligible patients that agree to participate will be provided written informed consent
      administered by the collaborators listed on this Institutional Review Board (IRB) at the
      above clinic locations. In addition to a standardized evaluation including the history and
      physical examination, the patients will complete the validated health-related quality of life
      questionnaires SF-12 and Endometriosis Health Profile-30 (EHP-30) with additional questions
      to determine baseline pain and activity scales as well as daily pain medication use.

      Surgeries will be performed by two board certified gynecologic surgeons (TF and JG). JG will
      participate in the laparoscopic arm of the study (Beachwood Family Health and Surgery Center)
      while TF will participate in both arms (Cleveland Clinic main campus). The patients of JG
      randomized to robotic surgery will be performed by TF at Cleveland Clinic main campus.

      Additionally, after the surgery, the patients will complete the above questionnaires as well
      as diaries addressing narcotic use and quality of life at 6 weeks and 6 months. Completion of
      questionnaires and diaries is the only additional assessment that is specific to
      participation in this study that is not usually included as part of the standard care for the
      treatment of endometriosis. It should take no more than 10 minutes to complete the
      questionnaires and less than 5 minutes each day to complete the diaries. The study subjects
      will not be exposed to any additional risk by participating in this study except for the
      inconvenience of completing the questionnaires and daily diaries.

      The participants will be randomized preoperatively (at the time of surgery scheduling)
      according to a computer-generated randomization schedule with random block sizes with the use
      of the SAS statistical software package (SAS Institute, Cary, NC). All patients will be
      blinded to their assignment. Intraoperative randomization of the patients is not feasible due
      to the fact that the operating room staff and operating room assigned for a given case is
      different for robotic and traditional laparoscopic cases.

      Patients who do not choose to participate in this study will still be offered the standard
      evaluation and management including laparoscopic treatment of endometriosis as deemed
      appropriate by the primary surgeon. Robotic-assisted laparoscopic treatment of endometriosis
      is not routinely performed in this institution however, and thus is not considered part of
      the standard of care.

      Laparoscopic assisted resection of endometriosis will be performed using up to five 5mm.
      ports. An umbilical port will be placed for the laparoscope and additional ports as dictated
      by each individual surgery. The robotic-assisted resection of endometriosis will be performed
      using the da Vinci Surgical System (Intuitive Surgical Inc., Sunnyvale, CA, USA) using up to
      five ports as needed. An umbilical port will be placed for the laparoscope (10/12mm), a 5mm
      assistant port will be placed in the right lower quadrant and two or three 8 mm robotic ports
      will be placed in the lower quadrants bilaterally.

      The technique for resection of superficial and deep endometriosis will be performed in a
      standard fashion. All superficial lesions suspicious for endometriosis (pigmented and
      non-pigmented) will be completely resected until non-diseased peritoneal margins are
      visualized around the defect or will be fulgurized using bipolar energy; all deep lesions
      suspicious for endometriosis will be completely resected until non-diseased margins are
      visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for
      endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated.
      Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess
      for lower urinary tract injury in cases that require extensive ureterolysis).

      Patients that are found not to have endometriosis at the time of surgery will be excluded
      from the study. The robot will be docked for all cases assigned for this arm irrespective of
      the amount of disease encountered (including mild endometriosis).

      Data points recorded during the procedure will include: operating room time of entry and exit
      and time from incision to closure. From this information, the operating room costs and
      anesthesia costs, i.e., the amount that a provider must pay for goods or services, will be
      calculated. Estimated blood loss, perioperative and post-operative complications, and number
      of days in the hospital (in cases that warrant admission) will be calculated. The standard
      American Society of Reproductive Medicine (ASRM) intraoperative endometriosis scoring system
      will be documented at the end of each surgery. Procedure and inpatient hospital costs (if
      applicable) will also be determined. All the operating room data (including the primary
      outcome) will be collected by a research nurse or coordinator that will be assigned for this
      task (to optimize reliability of these measurements).

      Patients will complete their daily narcotic use, which will include oral as well as
      patient-controlled analgesia IV narcotic use in the hospital when applicable as well as
      quality of life diaries. Patients will return to clinic for a two week post-operative visit.

      Prior to surgery, the patients will undergo a physical examination by a physician who is
      blinded to the patient's surgical group assignments. Additionally, patients will fill out the
      SF-12 health survey, EHP-30 and activity assessment questionnaires, pain scale and daily pain
      medication / narcotic use at baseline.

      At the 2 week postoperative visit, a routine physical exam will be performed, the daily pain
      medication diary will be retrieved and the questionnaires for surgical pain and activity
      assessment will be applied.

      At 6 weeks and 6 months, the nurse or physician will repeat the questionnaires by email
      (using Redcap), mailed questionnaires or over the telephone (SF-12, EHP-30, pain scales,
      daily pain medication / narcotic use and activity assessment questionnaires). The physician
      or nurse will also collect all the intraoperative and inpatient data for this project as well
      as review the medical record for possible admissions and postoperative complications.

      All data points and demographic information will be recorded in a secured, password protected
      database on the Gynresearch drive that will only be assessed by the collaborators on this
      IRB. Subjects will only be identified by their Cleveland Clinic medical record number. It is
      necessary to identify patients in this manner so that their clinical progress (e.g.
      postoperative complications, emergency room visits) can be located and recorded on the
      database.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operative Time</measure>
    <time_frame>1st 24 hours</time_frame>
    <description>Operative time is defined as skin incision to skin closure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Baseline, 6-weeks, 6-months</time_frame>
    <description>Pain as estimated by endometriosis, Endometriosis Health Profile-30 (EHP-30). Score ranges from 0-100. Lower score denotes improvement. Pain: As score decreases, pain decreases. No subscales.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>Robotic Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Robotic surgery using the da Vinci Surgical System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic assisted resection of endometriosis will be performed using up to five 5mm ports.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic surgery</intervention_name>
    <description>The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect or will be fulgurized using bipolar energy; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
    <arm_group_label>Robotic Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Surgery</intervention_name>
    <description>The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect or will be fulgurized using bipolar energy; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
    <arm_group_label>Laparoscopy</arm_group_label>
    <other_name>Laparoscopy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women 18 years of age or greater who are to undergo laparoscopic treatment of presumed
             endometriosis, as determined clinically by the operating surgeon.

        Exclusion Criteria:

          -  suspected malignancy,

          -  medical illness precluding laparoscopy,

          -  inability to give informed consent,

          -  morbid obesity (BMI &gt; 44), or

          -  need for concomitant bowel resection and/or ureteral reanastomosis.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tommaso Falcone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2012</study_first_submitted>
  <study_first_submitted_qc>March 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2012</study_first_posted>
  <results_first_submitted>May 16, 2016</results_first_submitted>
  <results_first_submitted_qc>June 23, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 4, 2016</results_first_posted>
  <last_update_submitted>December 22, 2016</last_update_submitted>
  <last_update_submitted_qc>December 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endometriosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Robotic Surgery</title>
          <description>da Vinci Surgical System
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
        </group>
        <group group_id="P2">
          <title>Laparoscopy</title>
          <description>Laparoscopic assisted resection of endometriosis will be performed using up to five 5mm ports.
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Robotic</title>
          <description>Robotic surgery</description>
        </group>
        <group group_id="B2">
          <title>Laparoscopic</title>
          <description>Laparoscopic surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="73"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.3" spread="7.2"/>
                    <measurement group_id="B2" value="34.5" spread="8.5"/>
                    <measurement group_id="B3" value="34.5" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Operative Time</title>
        <description>Operative time is defined as skin incision to skin closure.</description>
        <time_frame>1st 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Robotic Surgery</title>
            <description>da Vinci Surgical System
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
          </group>
          <group group_id="O2">
            <title>Laparoscopy</title>
            <description>Laparoscopic assisted resection of endometriosis will be performed using up to five 5mm ports.
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time</title>
          <description>Operative time is defined as skin incision to skin closure.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.6" spread="48.8"/>
                    <measurement group_id="O2" value="101.6" spread="63.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Variance estimates for this power analysis were taken from Nezhat C, et al, 2010. We determined that 37 subjects in each arm were needed to detect a difference of â‰¥ 32 minutes in operating time between conventional and robotic surgery for endometriosis with 80% power and a significance level of 0.05.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.71</p_value>
            <p_value_desc>This p-value is from a single comparison between two arms for operative time.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain</title>
        <description>Pain as estimated by endometriosis, Endometriosis Health Profile-30 (EHP-30). Score ranges from 0-100. Lower score denotes improvement. Pain: As score decreases, pain decreases. No subscales.</description>
        <time_frame>Baseline, 6-weeks, 6-months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Robotic Surgery</title>
            <description>da Vinci Surgical System
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
          </group>
          <group group_id="O2">
            <title>Laparoscopy</title>
            <description>Laparoscopic assisted resection of endometriosis will be performed using up to five 5mm ports.
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
          </group>
        </group_list>
        <measure>
          <title>Pain</title>
          <description>Pain as estimated by endometriosis, Endometriosis Health Profile-30 (EHP-30). Score ranges from 0-100. Lower score denotes improvement. Pain: As score decreases, pain decreases. No subscales.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.2" spread="18.1"/>
                    <measurement group_id="O2" value="54.2" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.6" spread="23.7"/>
                    <measurement group_id="O2" value="25.3" spread="21.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.8" spread="26.5"/>
                    <measurement group_id="O2" value="21.5" spread="23.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Secondary analysis for pain at baseline for robotic vs conventional laparoscopy for endometriosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.53</p_value>
            <p_value_desc>This applies to Row title: Baseline</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Pain scores at 6 weeks comparison between robotic and laparoscopy.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.53</p_value>
            <p_value_desc>This applies to Row title: 6-weeks</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Pain scores at 6 months for robotic vs laparoscopy.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.48</p_value>
            <p_value_desc>This applies to Row title: 6-months</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Robotic Surgery</title>
          <description>da Vinci Surgical System
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect or will be fulgurized using bipolar energy; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
        </group>
        <group group_id="E2">
          <title>Laparoscopy</title>
          <description>Laparoscopic assisted resection of endometriosis will be performed using up to five 5mm ports.
Surgery for endometriosis: The technique for resection of superficial and deep endometriosis will be performed in a standard fashion. All superficial lesions suspicious for endometriosis (pigmented and non-pigmented) will be completely resected until non-diseased peritoneal margins are visualized around the defect or will be fulgurized using bipolar energy; all deep lesions suspicious for endometriosis will be completely resected until non-diseased margins are visualized in the tissue surrounding the defect. Cystectomy(ies) will be performed for endometrioma(s). The fascia of any port greater or equal to 10mm will be reapproximated. Cystoscopy would only be performed when deemed appropriate by the surgeon (e.g., to assess for lower urinary tract injury in cases that require extensive ureterolysis).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tommaso Falcone, M.D.</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216-444-1752</phone>
      <email>falcont@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

